Q/C Technologies, Inc. Cash
Q/C Technologies, Inc. (QCLS) had Cash of $987.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-04-15
- 2025-12-31: Cash $987.00K.
- 2025-09-30: Cash $6.90M.
- 2025-06-30: Cash $207.55K.
- 2024-12-31: Cash $173.15K.
| Period end | Cash |
|---|---|
| 2025-12-31 | $987.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $6.90M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $207.55K 10-Q · filed 2025-08-19 |
| 2024-12-31 | $173.15K 10-Q · filed 2025-11-19 |
| 2020-09-30 | $16.30M 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |